Overview of COVID19 In Hypertension Patients

Volume 5 - Issue 4

Sarah Alqurmalah*

Received: September 14, 2020;   Published: September 24, 2020

DOI: 10.32474/RRHOAJ.2020.05.000220

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Introduction: The coronavirus disease 2019 (COVID-19) is worldwide outbreak. Globally there are 21,159,730 reported confirmed cases and there is almost no country in the world that is not affected by COVID-19 (3). It is caused by severe acute respiratory syndrome coronavirus 2 respiratory syndrome coronavirus 2 (SARS-CoV-2) enter the cells through angiotensin converting enzyme 2 (ACE2) receptor that act as key regulator of blood pressure.

Objective: To summarize the most updated data on COVID-19 and hypertension.

Methodology: A PubMed and UpToDate search was completed in Clinical Queries using the key terms ‘COVID-19 in hypertension patients ‘and ‘COVID-19 ‘. The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews.

Result: 1099 patients with confirmed COVID-19, of which the single highest risk factor of infection was hypertension reported in 15% of patients. Meta-analysis of six studies (1527) patients, hypertension was present in 17.1% of patients with the infection. The median age of SARS-CoV-2–positive patients who died was 78.5 years. significantly higher usage of ARBs in hypertensive patients with moderate COVID-19 disease than those with a severe and critical course of disease. There is no advantage to any group of medications within RAAS inhibitors. There are no data regarding the association between RAAS inhibitors and the outcome.

Conclusion: There is a relation between COVID-19 and HTN and need more data to be clarify weather HTN is isolated risk factor or as a reflection of ACEI or ARB. Age is associated with COVID19.

Abbreviations: COVID-19; Hypertension; ACE; ARB

Abstract| Introduction| Hypertension| The association of HTN and COVID-19| The association of age and COVID-19| ACE2 and ARB| References|